Corrigendum: CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder - Martucci, Cataldo; Allen, Andrew Dennis; Moretto, Nadia; Bagnacani, Valentina; Fioni, Alessandro; Patacchini, Riccardo; Civelli, Maurizio; Villetti, Gino; Facchinetti, Fabrizio (Frontiers in Pharmacology, 2024)